Farmed Pig Castration: Welfare and Alternatives

Piglet castration without anesthesia is performed on hundreds of millions of male pigs annually to prevent boar taint, but alternatives including immunocastration and genetics exist.

Key Facts

Male pigs are castrated to prevent boar taint — an unpleasant odor in meat from intact males
Surgical castration without anesthesia is standard practice in most pig-producing countries
The EU has committed to phasing out surgical castration without pain relief but progress is slow
Immunocastration (Improvac) prevents boar taint without surgery using a two-injection vaccine
Genetic selection for low-taint males is a longer-term alternative under active research

Welfare Considerations

Piglet castration without anesthesia causes significant acute pain to hundreds of millions of animals annually. The procedure involves cutting the scrotum and removing the testicles of conscious piglets — a clearly painful intervention that laboratory studies show produces stress responses lasting hours. Pain relief through local anesthesia and anti-inflammatories is effective and increasingly required in some European countries, but adoption is limited by cost and skill requirements. Immunocastration avoids surgical pain entirely and is effective, but consumer resistance to "vaccine" labeling has limited market acceptance. The welfare case for eliminating painful castration is clear — the barrier is market and regulatory, not technical.

What You Can Do

Choose pork from producers using immunocastration or pain-managed surgical castration
Support campaigns to end unmedicated piglet castration in countries where it remains standard
Advocate for labeling standards that support consumer acceptance of immunocastration
Reduce conventional pork consumption given the scale of unmedicated castration in production systems